Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome.
Women with polycystic ovary syndrome (PCOS) exhibit an adverse cardiovascular risk profile, characteristic of the metabolic cardiovascular syndrome (MCS). The aim of this study was to determine the prevalence of coronary artery (CAC) and aortic (AC) calcification among middle-aged PCOS cases and controls and to explore the relationship among calcification, MCS, and other cardiovascular risk factors assessed 9 yr earlier. This was a prospective study of 61 PCOS cases and 85 similarly aged controls screened in 1993-1994 for risk factors and reevaluated in 2001-2002. The main outcome measures were CAC and AC, measured by electron beam tomography. Women with PCOS had a higher prevalence of CAC (45.9% vs. 30.6%) and AC (68.9% vs. 55.3%) than controls. After adjustment for age and body mass index, PCOS was a significant predictor of CAC (odds ratio = 2.31; P = 0.049). PCOS subjects were also 4.4 times more likely to meet the criteria for MCS than controls. High-density lipoprotein cholesterol and insulin appeared to mediate the PCOS influence on CAC. Interestingly, total testosterone was an independent risk factor for AC in all subjects after controlling for PCOS, age, and body mass index (P = 0.034). We conclude that women with PCOS are at increased risk of MCS and demonstrate increased CAC and AC compared with controls. Components of MCS mediate the association between PCOS and CAC, independently of obesity.
Talbott
E O
EO
Department of Epidemiology, University of Pittsburgh Graduate School of Health, 130 DeSoto Street, A526 Crabtree Hall/GSPH, Pittsburgh, Pennsylvania 15261, USA. eot1@pitt.edu.
Zborowski
J V
JV
Rager
J R
JR
Boudreaux
M Y
MY
Edmundowicz
D A
DA
Guzick
D S
DS
D000328:Adult; D001018:Aortic Diseases / Q000453:epidemiology / Q000209:etiology*; D002114:Calcinosis / Q000453:epidemiology / Q000209:etiology*; D003327:Coronary Disease / Q000453:epidemiology / Q000209:etiology*; D005260:Female; D006801:Humans; D024821:Metabolic Syndrome / Q000209:etiology*; D008875:Middle Aged; D011085:Polycystic Ovary Syndrome / Q000150:complications*; D015995:Prevalence; D011446:Prospective Studies; D012307:Risk Factors